TetraScience Launches Scientific AI Lighthouse Program with Takeda as Founding Partner
Boston-based TetraScience has launched its Scientific AI Lighthouse (SAIL) program, with Takeda as the founding partner, announced in a press release.
The SAIL program introduces a model aimed at transforming bio-pharmaceutical research and manufacturing using AI. As the founding SAIL partner, Takeda gains early access to TetraScience’s complete data and AI capabilities to accelerate AI-driven drug discovery, shorten chemistry, manufacturing, and control (CMC) cycles, enable in silico modeling, and enhance scientific productivity through agentic AI.
The initiative is designed to help bio-pharmaceutical organizations bring more products to market at lower costs and reduced risk by improving candidate quality and operational efficiency.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation
The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.
Read more